While the coordinated timing among C-suite executives is notable, the dollar amount is not material relative to company size and is consistent with routine portfolio management. Traders should monitor for follow-up filings; absence of further large sales suggests this may not signal negative outlook.
Price Chart
Executive Summary
Three corporate insiders at Apogee Therapeutics, including the CEO, CFO, and CMO, sold shares totaling $1.77 million over a 7-day period, with the majority of the activity coming from CEO Michael Thomas Henderson's $1.47 million open-market sale. This represents coordinated selling by top executives, though the total value remains below 0.1% of the company's $6.0B market cap.
Key Financial Metrics
Key Facts
- Insider cluster involves three C-suite executives: CEO, CFO, and CMO.
- Total value of sales: $1.77 million, all via open-market transactions (S).
- CEO Michael Thomas Henderson sold $1.47 million of shares, accounting for 83% of the total cluster value.
- Sales occurred between 2026-04-01 and 2026-04-08, indicating concentrated timing.
- Total insider selling represents approximately 0.03% of Apogee Therapeutics' $6.0B market capitalization.
Financial Impact
Total insider sales amount to $1.77M, or 0.03% of market cap — below the 0.1% threshold for materiality.
Risk Factors
- Perception risk: Concentrated selling by top executives could be interpreted negatively by retail investors.
- Timing risk: Clustered sales around potential news events (e.g., upcoming earnings or clinical data) could imply information asymmetry.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-APGE-1775865642863 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 18d ago | 15-12G | — | awaiting T+5 | — | — |
Sep 3, 2026 29d ago | 25-NSE | $135.06 awaiting T+5 | awaiting T+5 | — | — |
Sep 3, 2026 29d ago | 8-K | $135.06 awaiting T+5 | awaiting T+5 | — | — |
Aug 11, 2026 7w ago | 8-K | $134.55 $134.71 | ▲ +0.12% | ▲ +0.56% | — |
Aug 10, 2026 7w ago | 8-K | $134.65 $134.59 | ▼ −0.04% | ▲ +0.00% | — |
Aug 10, 2026 7w ago | Press Release | $134.65 $134.59 | ▼ −0.04% | ▲ +0.00% | — |
Aug 6, 2026 8w ago | Institutional Cluster | $134.49 $134.45 | ▼ −0.03% | ▼ −1.24% | — |
Aug 3, 2026 8w ago | DEFA14A | $134.19 $134.69 | ▲ +0.37% | ▲ +0.47% | — |
Jul 11, 2026 11w ago | Insider Cluster | $133.82 $134.00 | ▲ +0.13% | ▲ +0.92% | — |
Jun 26, 2026 13w ago | DEFA14A | $132.61 $133.50 | ▲ +0.67% | ▼ −0.72% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access